Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on GST-HG171 Tablets
Clinical trial NCT05668897 · COMPLETED
Trial details
- NCT number
- NCT05668897
- Sponsor
- Fujian Akeylink Biotechnology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-01
- Primary completion
- 2022-12-02
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.